MNTA: listening to Teva's Jan 7th webcast. Bill Marth was adamant about believing that generic Copaxone applicants will have to run comprehensive clinical studies. He does not believe anyone can fully characterize a polypeptide with permutations up to 10 to the 28th power. He sounds a little bit defensive. How old is Bill Marth? He sounds like he is 18 years old. Sounds like Anthony Michael Halls best friend in the movie Weird Science. I hope he is wrong.
Market Data 
Markets 
AI
